142 related articles for article (PubMed ID: 10048898)
1. Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy.
Phillips P; Kwiatkowski MB; Copland M; Craib K; Montaner J
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):122-8. PubMed ID: 10048898
[TBL] [Abstract][Full Text] [Related]
2. [Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy].
Schwietert M; Battegay M
Dtsch Med Wochenschr; 1999 Jan; 124(3):45-8. PubMed ID: 9987485
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial lymphadenitis after initiation of highly active antiretroviral therapy.
Cabié A; Abel S; Brebion A; Desbois N; Sobesky G
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):812-3. PubMed ID: 9923530
[No Abstract] [Full Text] [Related]
4. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.
Race EM; Adelson-Mitty J; Kriegel GR; Barlam TF; Reimann KA; Letvin NL; Japour AJ
Lancet; 1998 Jan; 351(9098):252-5. PubMed ID: 9457095
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
Pulido F; Iribarren JA; Kindelan JM; Moreno S
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
8. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.
Gkentzi D; Tebruegge M; Tudor-Williams G; Walters S; Lyall H; Sharland M; Doerholt K
Pediatr Infect Dis J; 2014 Sep; 33(9):953-8. PubMed ID: 24618936
[TBL] [Abstract][Full Text] [Related]
9. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
[TBL] [Abstract][Full Text] [Related]
10. Soft tissue abscess and lymphadenitis due to Mycobacterium avium complex as an expression of immune reconstitution inflammatory syndrome after a second scheme of highly active antiretroviral therapy.
Corti M; Villafañe MF; Ambroggi M; Sawicki M; Gancedo E
Rev Inst Med Trop Sao Paulo; 2007; 49(4):267-70. PubMed ID: 17823760
[TBL] [Abstract][Full Text] [Related]
11. [Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment].
Fonquernie L; Meynard JL; Kirstetter M; Prévot S; Le Van JC; Meyohas MC; Frottier J
Presse Med; 2000 Feb; 29(4):186-7. PubMed ID: 10705894
[TBL] [Abstract][Full Text] [Related]
12. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
Kirk O; Gatell JM; Mocroft A; Pedersen C; Proenca R; Brettle RP; Barton SE; Sudre P; Phillips AN
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):865-72. PubMed ID: 10988097
[TBL] [Abstract][Full Text] [Related]
13. Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study.
Furrer H; Telenti A; Rossi M; Ledergerber B
AIDS; 2000 Jul; 14(10):1409-12. PubMed ID: 10930156
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts.
Hassell M; French MA
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):889-91. PubMed ID: 11837642
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial infection in patients with AIDS.
Tuon FF; Mulatti GC; Pinto WP; de Siqueira Franca FO; Gryschek RC
AIDS Patient Care STDS; 2007 Aug; 21(8):527-32. PubMed ID: 17711377
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Shirasaka T
Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
[TBL] [Abstract][Full Text] [Related]
17. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of mycobacterial infections in HIV infection.
Coker RJ; Hellyer TJ; Brown IN; Weber JN
Res Microbiol; 1992 May; 143(4):377-81. PubMed ID: 1455064
[No Abstract] [Full Text] [Related]
19. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.
Pechère M; Opravil M; Wald A; Chave JP; Bessesen M; Sievers A; Hein R; von Overbeck J; Clark RA; Tortoli E
Arch Intern Med; 1995 Feb; 155(4):400-4. PubMed ID: 7848023
[TBL] [Abstract][Full Text] [Related]
20. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
